NM23-HI immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas
1998

NM23-H1 and Colorectal Cancer Staging

Sample size: 141 publication Evidence: moderate

Author Information

Author(s): PY Cheah, X Cao, KW Eu, F Seow-Choen

Primary Institution: Singapore General Hospital

Hypothesis

Is NM23-H1 immunostaining correlated with tumour stage, overall survival, and disease recurrence in colorectal carcinomas?

Conclusion

NM23-H1 expression is inversely correlated with tumour staging but does not predict overall survival or disease recurrence in colorectal cancer.

Supporting Evidence

  • NM23-H1 expression was significantly higher in early-stage colorectal cancer compared to late-stage.
  • NM23-H1 expression did not correlate with overall survival or disease recurrence.
  • The study included a total of 141 patients with colorectal cancer.

Takeaway

This study found that a protein called NM23-H1 is more common in early-stage colorectal cancer but doesn't help predict if someone will survive or have their cancer come back.

Methodology

The study used immunostaining on 141 paraffin-embedded surgical specimens and analyzed the data using chi-square analysis.

Limitations

The study may not be generalizable beyond the Singapore population, and the sample included a majority of moderately differentiated tumors.

Participant Demographics

53 women and 88 men, predominantly Chinese, aged between 50 and over 71.

Statistical Information

P-Value

0.0004

Statistical Significance

p=0.0004

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication